In the Spotlight - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

In the Spotlight
Editors' Picks of Pharmaceutical Science & Technology Innovations

Pharmaceutical Technology


DynaPro plate reader (Wyatt Technology)
Plate reader provides efficiency and control
Wyatt Technology (Santa Barbara, CA) introduced a new version of its "Dyna-Pro" plate reader that can analyze well-plate samples, thus improving efficiency. The instrument controls the well plate's temperature between 4–70 C. Dr. Michael Larkin, a senior scientist with the company, adds that the reader can measure as little as 4 μL of sample in a 1536-well plate. "We dropped the sample requirement by a factor of 10, and, our minimum detectable concentration dropped significantly as well," Larkin observes. He explains that the device requires one third the sample volume for well-plate measurements as is typically required for batch measurements.

The DynaPro reader attenuates collected light and adjusts the laser power, resulting in a 1 part in 106 increase in dynamic range of possible sample concentrations. This adjustability allows users to analyze samples ranging from dilute, low scattering samples to turbid, milky samples. The reader is appropriate for crystallography and formulation applications.


Checker 200 series inspection sensor (Cognex)
Inspection sensor provides accuracy
The "Checker 200" series inspection sensors from Cognex (Natick, MA) incorporate vision technology to detect and recognize parts. The vision technology ensures the units are accurate and "less likely to be tricked" than traditional sensors, according to John Keating, product marketing manager at Cognex. The devices track parts and move their brightness, contrast, and pattern-inspection sensors with the parts to overcome varying product positioning, Keating notes.

Keating says the Checker 200 sensors have several advantages over traditional sensors. For example, the units inspect multiple elements on a product simultaneously without additional wiring. The devices also inspect a large area, rather than one point, as traditional sensors do, and are not subject to imprecise part handling. In addition, the Checker 200 units look for details such as product codes that traditional sensors cannot recognize. The devices are appropriate for package inspections and quality-control applications.


AccuGauge AG200 pressure gauge (American Sensor Technologies)
Gauge displays readings in various units
American Sensor Technologies (Mt. Olive, NJ) offers its "AccuGauge AG200" digital pressure gauge, which features a built-in display that shows real-time measurements in various units. Users can change pressure units to psi, bar, kg/cm2 , ATM, in. H2O, or Hg during operation without affecting the device's calibration, according to Karmjit S. Sidhu, the company's vice-president of business development. Users can change the device's calibration by 10% while maintaining the 4–20-mA output signal.

The pressure sensor is a one-piece, stainless steel unit without o-rings or internal wells. This design ensures that the sensor withstands various media and does not contaminate users' processes. The core of the sensing element is composed of inorganic materials that do not degrade, thereby providing the element with long-term stability.

New Product Announcements
May be sent to New Products Editor, Pharmaceutical Technology, 485 Route One South, Building F, First Floor, Iselin, NJ 08830, fax 732.596.0005,
.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
Source: Pharmaceutical Technology,
Click here